← Back to Clinical Trials
Recruiting NCT07841392

NCT07841392 Recall and Perceived Applicability of Ganzouri Airway Scoring System Versus LEMON Score for Airway Assessment Among Anesthesia Residents

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07841392
Status Recruiting
Phase —
Sponsor Cairo University
Condition Recall
Study Type OBSERVATIONAL
Enrollment 44 participants
Start Date 2026-09-01
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 28 Years
Study Type OBSERVATIONAL
Interventions
Ganzouri Airway Scoring SystemLEMON Score

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 44 participants in total. It began in 2026-09-01 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Our aim is to compare the recall and perceived clinical applicability of Ganzouri airway scoring system versus LEMON score for airway assessment from residents' perspective.

Eligibility Criteria

Inclusion Criteria: * Enrolled anesthesiology residents. * Currently training at Kasr Al-Ainy Hospitals. * Willing to participate and provide informed consent. * Available for entire study duration (baseline through 2-week followup). * First-year residents who didn't receive training in Ganzouri or LEMON Airway scoring systems. Exclusion Criteria: * Residents with prior formal training in either Ganzouri or LEMON Airway scoring systems (defined as structured lecture or workshop exceeding 30 minutes). * Residents who will be on leave, rotation at external sites, or otherwise unavailable during the 2-week follow-up period. * Refusal to participate or provide consent.

Contact & Investigator

Central Contact

Ghada A Sherif, MD

✉ drghadasherif@gmail.com

📞 00201006153615

Frequently Asked Questions

Who can join the NCT07841392 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 28 Years, studying Recall. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07841392 currently recruiting?

Yes, NCT07841392 is actively recruiting participants. Contact the research team at drghadasherif@gmail.com for enrollment information.

Where is the NCT07841392 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07841392 clinical trial?

NCT07841392 is sponsored by Cairo University. The trial plans to enroll 44 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology